Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 417

1.

Autologous non-myeloablative haematopoietic stem cell transplantation for refractory systemic vasculitis.

Statkute L, Oyama Y, Barr WG, Sufit R, Ho S, Verda L, Loh Y, Yaung K, Quigley K, Burt RK.

Ann Rheum Dis. 2008 Jul;67(7):991-7. Epub 2007 Oct 18.

PMID:
17947303
2.

Autologous haematopoietic stem cell transplantation without CD34+ cell selection in refractory Crohn's disease.

Cassinotti A, Annaloro C, Ardizzone S, Onida F, Della Volpe A, Clerici M, Usardi P, Greco S, Maconi G, Porro GB, Deliliers GL.

Gut. 2008 Feb;57(2):211-7. Epub 2007 Sep 25.

PMID:
17895357
3.

Autologous hemopoietic stem cell transplantation in severe rheumatoid arthritis: a report from the EBMT and ABMTR.

Snowden JA, Passweg J, Moore JJ, Milliken S, Cannell P, Van Laar J, Verburg R, Szer J, Taylor K, Joske D, Rule S, Bingham SJ, Emery P, Burt RK, Lowenthal RM, Durez P, McKendry RJ, Pavletic SZ, Espigado I, Jantunen E, Kashyap A, Rabusin M, Brooks P, Bredeson C, Tyndall A.

J Rheumatol. 2004 Mar;31(3):482-8.

PMID:
14994391
4.

Autologous bone marrow transplantation in the treatment of refractory systemic sclerosis: early results from a French multicentre phase I-II study.

Farge D, Marolleau JP, Zohar S, Marjanovic Z, Cabane J, Mounier N, Hachulla E, Philippe P, Sibilia J, Rabian C, Chevret S, Gluckman E; Intensification et Autogreffe dans les Maladies Auto Immunes Resistantes (ISAMAIR) Study Group..

Br J Haematol. 2002 Dec;119(3):726-39.

PMID:
12437652
5.

Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia.

Liu QF, Fan ZP, Zhang Y, Jiang ZJ, Wang CY, Xu D, Sun J, Xiao Y, Tan H.

Biol Blood Marrow Transplant. 2009 Nov;15(11):1376-85. doi: 10.1016/j.bbmt.2009.06.017. Epub 2009 Aug 19.

6.

Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease.

Binks M, Passweg JR, Furst D, McSweeney P, Sullivan K, Besenthal C, Finke J, Peter HH, van Laar J, Breedveld FC, Fibbe WE, Farge D, Gluckman E, Locatelli F, Martini A, van den Hoogen F, van de Putte L, Schattenberg AV, Arnold R, Bacon PA, Emery P, Espigado I, Hertenstein B, Hiepe F, Kashyap A, Kötter I, Marmont A, Martinez A, Pascual MJ, Gratwohl A, Prentice HG, Black C, Tyndall A.

Ann Rheum Dis. 2001 Jun;60(6):577-84.

7.

Autologous hematopoietic stem cell transplantation in patients with refractory Crohn's disease.

Oyama Y, Craig RM, Traynor AE, Quigley K, Statkute L, Halverson A, Brush M, Verda L, Kowalska B, Krosnjar N, Kletzel M, Whitington PF, Burt RK.

Gastroenterology. 2005 Mar;128(3):552-63.

PMID:
15765390
8.

Autologous stem cell transplantation of treatment-resistant systemic vasculitis--a single center experience and review of the literature.

Kötter I, Daikeler T, Amberger C, Tyndall A, Kanz L.

Clin Nephrol. 2005 Dec;64(6):485-9. Review.

PMID:
16370165
9.

Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine.

Mori T, Aisa Y, Watanabe R, Yamazaki R, Kato J, Shimizu T, Shigematsu N, Kubo A, Yajima T, Hibi T, Ikeda Y, Okamoto S.

Biol Blood Marrow Transplant. 2008 Jun;14(6):651-7. doi: 10.1016/j.bbmt.2008.03.006.

10.

Hematopoietic stem cell transplantation for severe and refractory lupus. Analysis after five years and fifteen patients.

Traynor AE, Barr WG, Rosa RM, Rodriguez J, Oyama Y, Baker S, Brush M, Burt RK.

Arthritis Rheum. 2002 Nov;46(11):2917-23.

11.

Intense immunosuppressive therapy followed by autologous peripheral blood selected progenitor cell reinfusion for severe autoimmune disease.

Musso M, Porretto F, Crescimanno A, Bondi F, Polizzi V, Scalone R.

Am J Hematol. 2001 Feb;66(2):75-9.

12.

Total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine as a conditioning regimen in allogeneic hematopoietic stem cell transplantation for advanced myelodysplastic syndrome: a single-institute experience.

Mori T, Aisa Y, Yokoyama A, Nakazato T, Yamazaki R, Shimizu T, Mihara A, Kato J, Watanabe R, Takayama N, Ikeda Y, Okamoto S.

Bone Marrow Transplant. 2007 Feb;39(4):217-21. Epub 2007 Jan 15.

PMID:
17220902
13.

High-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with rheumatoid arthritis: results of an open study to assess feasibility, safety, and efficacy.

Verburg RJ, Kruize AA, van den Hoogen FH, Fibbe WE, Petersen EJ, Preijers F, Sont JK, Barge RM, Bijlsma JW, van de Putte LB, Breedveld FC, van Laar JM.

Arthritis Rheum. 2001 Apr;44(4):754-60.

14.

Autologous non-myeloablative hematopoietic stem cell transplantation in patients with systemic sclerosis.

Oyama Y, Barr WG, Statkute L, Corbridge T, Gonda EA, Jovanovic B, Testori A, Burt RK.

Bone Marrow Transplant. 2007 Sep;40(6):549-55. Epub 2007 Jul 23.

PMID:
17646844
15.

Substitution of methotrexate for cyclophosphamide in Wegener granulomatosis: a 12-year single-practice experience.

Villa-Forte A, Clark TM, Gomes M, Carey J, Mascha E, Karafa MT, Roberson G, Langford CA, Hoffman GS.

Medicine (Baltimore). 2007 Sep;86(5):269-77.

16.

Favourable results with a single autologous stem cell transplant following conditioning with busulphan and cyclophosphamide in patients with multiple myeloma.

Toor AA, Ayers J, Strupeck J, Parthasarathy M, Creech S, Rodriguez T, Stiff PJ.

Br J Haematol. 2004 Mar;124(6):769-76.

PMID:
15009065
17.

Fludarabine-based conditioning secures engraftment of second hematopoietic stem cell allografts (HSCT) in the treatment of initial graft failure.

Chewning JH, Castro-Malaspina H, Jakubowski A, Kernan NA, Papadopoulos EB, Small TN, Heller G, Hsu KC, Perales MA, van den Brink MR, Young JW, Prockop SE, Collins NH, O'Reilly RJ, Boulad F.

Biol Blood Marrow Transplant. 2007 Nov;13(11):1313-23. Epub 2007 Sep 7.

18.

Hematopoietic stem cell transplantation (HSCT) for primary systemic vasculitis and related diseases.

Fiehn C, Ho AD, Lorenz HM.

Autoimmunity. 2008 Dec;41(8):648-53. doi: 10.1080/08916930802197495. Review.

PMID:
18958761
19.

[Stem cell transplantation in primary systemic vasculitis].

Hensel M, Fiehn C, Ho AD.

Med Klin (Munich). 2003 Jan 15;98(1):13-8. Review. German.

PMID:
12540989
20.

Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis.

Vonk MC, Marjanovic Z, van den Hoogen FH, Zohar S, Schattenberg AV, Fibbe WE, Larghero J, Gluckman E, Preijers FW, van Dijk AP, Bax JJ, Roblot P, van Riel PL, van Laar JM, Farge D.

Ann Rheum Dis. 2008 Jan;67(1):98-104. Epub 2007 May 25. Erratum in: Ann Rheum Dis. 2008 Feb;67(2):280.

PMID:
17526554

Supplemental Content

Support Center